Sfoglia per Rivista
Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993.
1994-01-01 LANZA F ;MORETTI S ;PAPA S ;MALAVASI F ;CASTOLDI G
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
2007-01-01 SOVERINI S; COLAROSSI S; GNANI A; CASTAGNETTI F; ROSTI G; BOSI C; PAOLINI S; RONDONI M; PICCALUGA PP; PALANDRI F; GIANNOULIA P; MARZOCCHI G; LUATTI S; TESTONI N; IACOBUCCI I; CILLONI D; SAGLIO G; BACCARANI M; MARTINELLI G
RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
2014-01-01 Latagliata, R; Stagno, F; Annunziata, M; Iurlo, A; Scappini, B; Guarini, A; Giglio, G; Fava, C; Sora, F; Capodanno, I; Crugnola, M; Crescenzi, Sl; Barsotti, S; Feo, C; Breccia, M; Vigneri, P; Cambrin, Gr; Gozzini, A; Alimena, G
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients.
1996-01-01 LEVIS A ;DEPAOLI L ;BERTINI M ;BOTTO B ;CIRAVEGNA G ;FREILONE R ;GALLAMINI A ;GAVAROTTI P ;RICARDI U ;SCALABRINI DR ;SALOMONE A ;SALVI F ;VITOLO U ;PILERI A ;SANNAZZARI GL ;RESEGOTTI L
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival
2014-01-01 Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U
Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM)
2011-01-01 G MORGAN; B DURIE; J SAN MIGUEL; R ORLOWSKI; S LONIAL; A PALUMBO; R NIESVIZKY; R BAZ; S GIRALT; W BENSINGER; N BRANDENBURG; Z YU; M BOCCADORO; P RICHARDSON; K ANDERSON; B BARLOGIE
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.
2003-01-01 ROSTI G; TRABACCHI E; BASSI S; BONIFAZI F; DE VIVO A; MARTINELLI G; ALBERTI; D; FINCATO G; G. SAGLIO; BACCARANI M; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC; MYELOID LEUKEMIA.
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001-01-01 GUGLIELMI C ;MARTELLI M ;FEDERICO M ;ZINZANI PL ;VITOLO U ;BELLESI G ;SANTINI G ;TARELLA C ;ZALLIO F ;PREGNO P ;DI RENZO N ;RESEGOTTI L
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML
2016-01-01 S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio
Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
2002-01-01 Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio
ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE
2013-01-01 Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA
2013-01-01 Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY
2015-01-01 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive?
2016-01-01 Ferrero, Simone
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation
2010-01-01 Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A
SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION
2006-01-01 L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro
Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
2014-01-01 T. P. Hughes;A. Hochhaus;H. M. Kantarjian;F. Cervantes;F. Guilhot;D. Niederwieser;P. D. le Coutre;G. Rosti;G. Ossenkoppele;C. Lobo;H. Shibayama;X. Fan;H. D. Menssen;C. Kemp;R. A. Larson;G. Saglio
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
2013-01-01 Palumbo A1; Waage A; Hulin C; Beksac M; Zweegman S; Gay F; Gimsing P; Leleu X; Wijermans P; Sucak G; Pezzatti S; Juliusson G; Pégourié B; Schaafsma M; Galli M; Turesson I; Kolb B; van der Holt B; Baldi I; Rolke J; Ciccone G; Wetterwald M; Lokhorst H; Boccadoro M; Rodon P; Sonneveld P.
Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin.
1990-01-01 ALFARANO A.; GOTTARDI E.; SERRA A.; PIGA A.; MANDRINO M.; MAZZA U.; CAMASCHELLA C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993. | 1994 | LANZA F ;MORETTI S ;PAPA S ;MALAVASI F ;CASTOLDI G | |
| Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain | 2007 | SOVERINI S; COLAROSSI S; GNANI A; CASTAGNETTI F; ROSTI G; BOSI C; PAOLINI S; RONDONI M; PICCALUGA PP; PALANDRI F; GIANNOULIA P; MARZOCCHI G; LUATTI S; TESTONI N; IACOBUCCI I; CILLONI D; SAGLIO G; BACCARANI M; MARTINELLI G | |
| RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 2014 | Latagliata, R; Stagno, F; Annunziata, M; Iurlo, A; Scappini, B; Guarini, A; Giglio, G; Fava, C; Sora, F; Capodanno, I; Crugnola, M; Crescenzi, Sl; Barsotti, S; Feo, C; Breccia, M; Vigneri, P; Cambrin, Gr; Gozzini, A; Alimena, G | |
| Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients. | 1996 | LEVIS A ;DEPAOLI L ;BERTINI M ;BOTTO B ;CIRAVEGNA G ;FREILONE R ;GALLAMINI A ;GAVAROTTI P ;RICARDI U ;SCALABRINI DR ;SALOMONE A ;SALVI F ;VITOLO U ;PILERI A ;SANNAZZARI GL ;RESEGOTTI L | |
| Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival | 2014 | Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U | |
| Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM) | 2011 | G MORGAN; B DURIE; J SAN MIGUEL; R ORLOWSKI; S LONIAL; A PALUMBO; R NIESVIZKY; R BAZ; S GIRALT; W BENSINGER; N BRANDENBURG; Z YU; M BOCCADORO; P RICHARDSON; K ANDERSON; B BARLOGIE | |
| Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia. | 2003 | ROSTI G; TRABACCHI E; BASSI S; BONIFAZI F; DE VIVO A; MARTINELLI G; ALBERTI; D; FINCATO G; G. SAGLIO; BACCARANI M; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC; MYELOID LEUKEMIA. | |
| Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. | 2001 | GUGLIELMI C ;MARTELLI M ;FEDERICO M ;ZINZANI PL ;VITOLO U ;BELLESI G ;SANTINI G ;TARELLA C ;ZALLIO F ;PREGNO P ;DI RENZO N ;RESEGOTTI L | |
| ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML | 2016 | S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio | |
| Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) | 2002 | Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio | |
| ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE | 2013 | Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F | |
| ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA | 2013 | Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont | |
| ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY | 2015 | G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti | |
| The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive? | 2016 | Ferrero, Simone | |
| ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 2004 | Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M | |
| Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation | 2010 | Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A | |
| SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION | 2006 | L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro | |
| Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily | 2014 | T. P. Hughes;A. Hochhaus;H. M. Kantarjian;F. Cervantes;F. Guilhot;D. Niederwieser;P. D. le Coutre;G. Rosti;G. Ossenkoppele;C. Lobo;H. Shibayama;X. Fan;H. D. Menssen;C. Kemp;R. A. Larson;G. Saglio | |
| Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials. | 2013 | Palumbo A1; Waage A; Hulin C; Beksac M; Zweegman S; Gay F; Gimsing P; Leleu X; Wijermans P; Sucak G; Pezzatti S; Juliusson G; Pégourié B; Schaafsma M; Galli M; Turesson I; Kolb B; van der Holt B; Baldi I; Rolke J; Ciccone G; Wetterwald M; Lokhorst H; Boccadoro M; Rodon P; Sonneveld P. | |
| Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin. | 1990 | ALFARANO A.; GOTTARDI E.; SERRA A.; PIGA A.; MANDRINO M.; MAZZA U.; CAMASCHELLA C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile